Abstract: An apparatus for processing crustaceans comprising a feeder for feeding crustaceans to a singulating and conveying device, said singulating and conveying device delivering the crustaceans individually to at least one separating device, said at least one separating device separating the tail section of each crustacean from the head section thereof.

Abstract: An apparatus for processing crustaceans comprising a feeder for feeding crustaceans to a singulating and conveying device, said singulating and conveying device delivering the crustaceans individually to at least one separating device, said at least one separating device separating the tail section of each crustacean from the head section thereof.

Abstract: A network device for scheduling packets in a plurality of queues. The network device includes a plurality of configurable mechanisms, each of which is configured to process information in one of a plurality of queues based on a predefined bandwidth. A scheduler services an associated one of the plurality of queues based on the predefined bandwidth. The network device also includes means for tracking whether or not the plurality of queues has exceeded a predefined threshold. If the plurality of queues has exceeded the predefined threshold, a new bandwidth allocation is calculated for each of the plurality of queues. The new bandwidth allocation replaces the predefined bandwidth and is proportional to the predefined bandwidth for each of the plurality of queues.

Abstract: The present invention relates to methods and compositions for the delivery of cosmetics and medicants. In some embodiments, the invention relates to compositions comprising both hydrophobic and hydrophilic polymers. In preferred embodiments, the invention relates to the delivery of peptides, small molecules and other bioactive compounds using the compositions and methods disclosed herein.

Abstract: The present invention provides compounds of the formula wherein R1, R2 and B are as herein described, pharmaceutical compositions comprising these compounds, use of these compounds for the preparation of pharmaceutical compositions and methods of use thereof for the treatment and/or prevention of disorders and diseases wherein modulation of the H3 receptor is beneficial.

Abstract: A network device for dynamically allocating memory locations to plurality of queues. The network device includes an assigning means for assigning a predefined amount of a temporary memory buffer and a shared memory buffer to each of a plurality of ports and for allocating a fixed allocation of the temporary memory buffer and the shared memory buffer to each of a plurality of queues associated with each port. After each queue has accumulated a predefined portion of data in the temporary memory buffer, the data is transmitted to the shared memory. The means for assigning reduces the shared memory access bandwidth by a predefined amount that is less than a processing bandwidth of a system clock.

Abstract: A network device for correcting corrupted memory locations. The network device includes a plurality of free pointers, each of which points to a free memory location. The network device also includes a plurality of cell locations for storing information, each of the plurality of cell locations comprising a field for storing a pointer to another cell location. Upon retrieving information from one of the plurality of cell locations, the device includes means for determining if the pointer to the current cell location is valid and for storing a valid pointer with the plurality of free pointers.

Abstract: A novel class of substituted homopiperidine, piperidine and pyrrolidine derivatives, methods for their preparation, pharmaceutical compositions comprising them and use thereof in the treatment of disorders related to the histamine H3 receptor. More particularly, the compounds possess histamine H3 receptor antagonistic activity and are thus useful in the treatment of disorders in which a histamine H3 receptor blockade is beneficial.

Abstract: A method and system for searching and collecting electronically stored information are described. Consistent with an embodiment of the invention, configuration and execution of a search are separated in time and location. For example, a search configuration application executing at a first computer system is utilized to generate a search configuration file, which controls the operation of a search agent when the search agent is executing at a target computer system and performing a search of storage devices act of the target computer system. Encryption is utilized to prevent unauthorized access to the search configuration file as well as the search results file generated by the search agent.

Abstract: Novel compounds which interact with the histamine H3 receptor are defined. These compounds are particularly useful in the treatment of a variety of diseases or conditions in which histamine H3 interactions are beneficial. Thus, the compounds may find use, e.g., in the treatment of diseases of the central nervous system, the peripheral nervous system, the cardiovascular system, the pulmonary system, the gastrointestinal system and the endocrinological system. The novel compounds have a core consisting of a 6 membered aromatic ring containing at least one nitrogen atom and two carbon atoms in the ring and, at the remaining positions in the ring, there is either a carbon or a nitrogen atom.

Abstract: An expandable stent comprising a tubular body made up of a plurality of separated tubular elements (1) arranged along a common longitudinal axis. Each tubular element (1) comprises a plurality of rhombic-shaped closed cell elements (2) joined by circumferentially extending linking members (3). The closed cell elements (2) are expandable to allow the tubular elements, and hence the stent itself, to expand. In the direction of the longitudinal axis of the stent, the extremities of each of the closed cell elements has an enlarged loop (30) with waisted portions (33) which allow the tubular elements to interlock to create a stable structure, at least when in the unexpanded condition.

Abstract: A network device for dynamically allocating memory locations to plurality of queues. The network device includes means for determining an amount of memory buffers that is associated with a port, for assigning a fixed allocation of memory buffers to each of a plurality of queues associated with the port and for sharing remaining memory buffers among the plurality of queues. The remaining memory buffers are used by each of the plurality of queues after the fixed allocation of memory buffers assigned to the queue is used. The network device also includes means for setting a limit threshold for each of the plurality of queues. The limit threshold determines how much of the remaining memory buffer may be used by each of the plurality of queues. The network device further includes means for defining at least one color threshold for packets including a specified color marking and for defining a virtual maximum threshold.

Abstract: A method of handling data in a memory of a network device is disclosed. The method includes the steps of storing portions of a datagram, being handled by a network device, in a memory, where the memory comprises two logic memory blocks, storing at least two pointers with the portions of the datagram in the memory, where one of the at least two pointers points to a next portion of the memory to be accessed, retrieving the portions of the datagram and the at least two pointers when the network device is ready to act on the datagram, polling a register to determine which of the at least two pointers actually points to the next portion, retrieving the next portion, when necessary and acting on the datagram based on the processing of the datagram by the network device.

Abstract: A network device for dynamically allocating memory locations to plurality of queues. The network device includes means for determining an amount of memory buffers that is associated with a port, for assigning a fixed allocation of memory buffers to each of a plurality of queues associated with the port and for sharing remaining memory buffers among the plurality of queues. The remaining memory buffers are used by each of the plurality of queues after the fixed allocation of memory buffers assigned to the queue is used. The network device also includes means for setting a limit threshold for each of the plurality of queues. The limit threshold determines how much of the remaining memory buffer may be used by each of the plurality of queues. The network device further includes means for defining at least one color threshold for packets including a specified color marking and for defining a virtual maximum threshold.

Abstract: A stiffenable balloon catheter assembly capable of being converted from an “over-the-wire” mode with respect to a guidewire extending therethrough to a “rapid-exchange” mode with respect to a guidewire extending therethrough, and vice versa. The catheter has a plurality of lumens, one lumen however, having a side opening with an obstructable galp, the orientation of which, determines the utilization “mode” of the catheter assembly. Stiffening stylets may be adjustably locked into the lumens, depending upon the “mode”, to control the stiffness of the catheter assembly during its utilization within a patient.

Abstract: A network device for minimizing latency and correcting errors associated with information transmitted from an external memory device. The network device includes a management unit for requesting information stored on at least one external memory device. The network device also includes a command unit for transmitting a request from the management unit to the external memory device. The command unit maintain at least one counter that is associated with current requests and compares the at least one counter to at least one predefined threshold in order to throttle the management unit when the at least one counter exceeds the at least one threshold. The network device further includes means for aligning information from the at least one external memory device with information transmitted from the command unit to the management unit and for ensuring that aligned information is accurate.

Abstract: A novel class of substituted piperazines and diazepanes, pharmaceutical compositions comprising them and use thereof in the treatment of diseases and disorders related to the histamine H3 receptor. More particularly, the compounds are useful for the treatment of diseases and disorders in which an interaction with the histamine H3 receptor is beneficial.

Abstract: A novel class of substituted homopiperidine, piperidine and pyrrolidine derivatives, methods for their preparation, pharmaceutical compositions comprising them and use thereof in the treatment of disorders related to the histamine H3 receptor. More particularly, the compounds possess histamine H3 receptor antagonistic activity and are thus useful in the treatment of disorders in which a histamine H3 receptor blockade is beneficial.

Abstract: A network device for minimizing latency and correcting errors associated with information transmitted from an external memory device. The network device includes a management unit for requesting information stored on at least one external memory device. The network device also includes a command unit for transmitting a request from the management unit to the external memory device. The command unit maintain at least one counter that is associated with current requests and compares the at least one counter to at least one predefined threshold in order to throttle the management unit when the at least one counter exceeds the at least one threshold. The network device further includes means for aligning information from the at least one external memory device with information transmitted from the command unit to the management unit and for ensuring that aligned information is accurate.

Abstract: An expandable balloon for use in angioplasty procedures comprises a balloon having an outer surface layer, the outer surface layer being made from electrospun nanofibers and incorporating at least one pharmaceutically active substance, such as nitric oxide (NO). The outer surface layer may be formed on a separate flexible tubular member or sock, which is slipped over the balloon. An acidic agent, such as ascorbic acid, may be included in the balloon for enhancing NO release. A method of treating cell disorders in tubular structures of a living being comprises the steps of placing a coated balloon at a treatment site within the tubular structures, expanding the balloon at the treatment site, and releasing the pharmaceutically active substance at the treatment site. Optionally, a stent may be crimped onto the balloon prior to insertion of the balloon and stent into the tubular structures of the living being.